Sections & Products

Main > > >ANALGESIA. *

Acetaminophen BioSynthesis.
(*) Company; Patent APP. & Web-Site
Available on Request.
UpDate: 2018. 05.29.

Acetaminophen Injection 1000 mg/100 mL
(10mg/mL) Brand. (U)
USA Approval Date: 2010. 11.02.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.01.

Acetaminophen Injection 1000 mg/100 mL
(10mg/mL) Generic. (B)
Dossier Status: Available DCP completed
(2018. 01.)
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2018. 04.01.

Acetaminophen Injection 1000 mg/100 mL
500mg/50ml Generics. (I>A)
Presentation: Bags.
EU Launch Date: ?
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2018. 04.18.

Acetaminophen Injection 1000 mg/100 mL
(10mg/mL) Generic. (I>P)
USA Approval Date: 2016. 06.16.
(*) Company Available on Request.
UpDate: 2018. 04.01.

BenzHydrocodone+Acetaminophen Tablets.
BenzHydrocodone=ProDrug of Hydrocodone
Indication:
Short-Term (no more than 14 days) Management of acute Pain severe enough to require an Opioid analgesic.
USA Approval Date: 2018. 02.23.
USA Launch Date: 2019. 11.01.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 05.24.

Bupivacaine Liposome Injectable Suspen-
sion.
Indication: PostSurgical Pain.
USA Approval Date: 2011. 10.28.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 04.14.

Buprenorphine Buccal Film.
CA Approval Date : 2017. 06.23.
CA Launch Date : 2018. 01.30.
USA Approval Date: 2015. 10.26.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Capsaicin 8% Patch.
Indications:
- Diabetic PolyNeuropathy (DPN)
EU Approval Year: 2015.
- Peripheral NeuroPathy (PNP)
EU Approval Year: 2009
- PostHerpetic Neuralgia (PHN)
USA Approval: 2009. 11.16.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 11.26.

Cobra Venom.
Launch Date: 2018. 01.11.
(*) Companies; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Cooled RadioFrequency TREAT.
Indication>Chronic OA Knee Pain
USA Clearance Date: 2017. 04.20.
(*) Company : Halyard Health Inc.
www.halyardhealth.com
TradeMark: Coolief
Web-Site : www.mycoolief.com
UpDate: 2018. 04.02.

Diclofenac 75mg / 1ml injection.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Dorsal Root Ganglion (DRG) Stimulator
System.
Focal Chronic Pain of the Lower Limbs due to CRPS (Complex Regional Pain Syndrome)
USA Launch Date: 2017. 10.16.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

HydroCodone BiTartrate ER Capsules.
USA Approval Date: 2013. 10.25.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

HydroCodone BiTartrate ER Tablets [CII] Formulated with Proprietary Abuse Deterrence Technology.
USA Approval Date: 2017. 01.18.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Hydrocodone Bitartrate+Acetaminophen Tablets. Generic.
USA Approval Date: 2017. 06.22.
(*) Company Available on Request.
UpDate: 2018. 04.02.

HydroMorphone ER Tablets. Generic.
USA Approval Date: 2017. 09.21.
USA Launch Date : 2017. 11.27.
(*) Company Available on Request.
UpDate: 2018. 04.02.

Ketorolac Tromethamine Injection.
USA Approval Date: 2017. 09.19.
(*) Company: Cycle Pharmaceuticals.
UpDate: 2018. 08.30.

Ketorolac Tromethamine Tablets.
USA Approval Date: 2018. 08.29.
(*) Company: Cycle Pharmaceuticals.
UpDate: 2018. 08.30.

Methadone.HCl Tablet. Generics.
USA Approval Date: 2018. 08.06.
(*) Company: Elite Pharma.
UpDate: 2018. 08.07.

Morphine Sulfate ER Capsules. Generic.
USA Launch Date: 2016. 12.22.
(*) Company Available on Request.
UpDate: 2018. 04.02.

Morphine Sulfate ER Tablets. (E)
USA Approval Date: 2017. 01.09.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Morphine Sulfate ER Tablets. (I)
USA Approval Date: 2015. 10.05.
(*) Companies; Patent; TradeMarks &
Web-Sites Available on Request.
UpDate: 2018. 04.02.

Morphine Sulfate Oral Solution. Generic.
USA Approval Date: 2018. 04.18.
(*) Company Available on Request.
UpDate: 2018. 04.19.

Morphine Sulfate+Naltrexone.HCl ER Cap-
sules.
USA Approval Date: 2009. 08.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Near IR Therapy 633nm.
(*) Company; Patent APP., & Web-Site
Available on Request.
UpDate: 2018. 04.02.

NeuroModulation Device.
USA Clearance Date: 2017. 08.01.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

OxyCodone ER Capsules. Brand.
USA Launch Date: 2016. 06.20.
(*) Company; Patents; TradeMarks & Web-
Sites Available on Request.
UpDate: 2018. 04.02.

OxyCodone.HCl Capsules, 5 mg. Generic.
USA>Launch Date: 2016. 06.13.
(*) Company: Ani Pharma.
www.anipharmaceuticals.com
UpDate: 2018. 04.02.

OxyCodone.HCl ER Tablets.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

OxyCodone.HCl Oral Solution, 100 mg/5mL
Generic.
USA Launch Date: 2017. 09.01.
(*) Company: Ani Pharma.
www.anipharmaceuticals.com
UpDate: 2018. 04.02.

OxyCodone.HCl Tablets. (E)
USA Approval Date: 2011. 06.17.
(*) Company; Patents; TradeMarks & Web-
Sites Available on Request.
UpDate: 2018. 04.02.

OxyCodone.HCl Tablets. (I)
USA Approval Date: 2017. 04.26.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

OxyCodone+Acetaminophen. Generic.
USA Approval Date: 2017. 09.27.
(*) Company Available on Request.
UpDate: 2018. 04.02.

OxyCodone.HCl+Naltrexone.HCl ER Capsules
Abuse-Deterrent Properties.
USA Approval Date: 2016. 08.19.
(*) Company; TradeMark & Web-Site
Available on Request.
UpDate: 2018. 04.02.

OxyMorphone.HCl ER Tablets.
USA Approval Date: 2006. 06.22.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Post-Herpetic Neuralgia (PHN). Pain.
TREAT.: Lidocaine Topical System 1.8%.
USA Approval Date: 2018. 02.28.
(*) Company & TradeMark Available on
Request.
UpDate: 2018. 04.02.

PreGabalin Capsules.
USA Approval Date: 2004. 12.30.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

RemiFentanil.HCl for Injection. Generic.
USA Launch Date: 2018. 01.26.
(*) Company: Fresenius Kabi USA
www.fresenius-kabi.com/us/
UpDate: 2018. 04.02.

Spinal Cord Stimulation.
EU Approval Date: 2017. 11.06.
USA Launch Date : 2017. 09.18.
(*) Company: Medtronic.
UpDate: 2018. 04.01.

Spinal Cord Stimulation. (N)
USA Approval Date: 2018. 01.08.
(*) Company; Patents; PR Web-Site &
TradeMarks Available on Request.
UpDate: 2018. 04.02.

Spinal Cord Stimulation.
AU Approval Date : 2017. 04.07.
EU Approval Date : 2015. 12.10.
USA Approval Date: 2015. 12.09.
(*) Company : Stimwave LLC.
www.stimwave.com
TradeMark: Freedom System
UpDate: 2018. 04.02.

SuFentanil Sublingual Tablets 30 micro
gram. (U)
Medically Supervised Settings.
EU Approval Date: 2018. 06.27.
(*) Company; Patents; TradeMarks &
Web-Site Available on Request.
UpDate: 2018. 07.16.

Tapentadol ER Tablets.
Indications: . Diabetic Peripheral
Neuropathy Pain.
. Pain.
USA Approval Date: 2011. 08.25.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2018. 04.02.

TENS Wearable OTC Device.
USA Clearance Date: 2014. 07.08.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.02.

Tramadol.HCl ER Tablets 100, 200 & 300 mg.
Approved in CA & EU.
(*) Company; Patents; TradeMarks & Web-
Site Available on Request.
UpDate: 2018. 04.01.

Ziconotide Intrathecal Infusion.
Marine Snail Deriv Synthetic Equiv.
Peptide (ConoPeptide).
Severe Chronic Pain MAN.
USA Approval Date: 2004. 12.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 04.01.

>ANALGESIA. *'s products
This section has no products